2015
DOI: 10.7150/thno.10823
|View full text |Cite
|
Sign up to set email alerts
|

MRI Visible Drug Eluting Magnetic Microspheres for Transcatheter Intra-Arterial Delivery to Liver Tumors

Abstract: Magnetic resonance imaging (MRI)-visible amonafide-eluting alginate microspheres were developed for targeted arterial-infusion chemotherapy. These alginate microspheres were synthesized using a highly efficient microfluidic gelation process. The microspheres included magnetic clusters formed by USPIO nanoparticles to permit MRI and a sustained drug-release profile. The biocompatibility, MR imaging properties and amonafide release kinetics of these microspheres were investigated during in vitro studies. A xenog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
51
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 61 publications
(52 citation statements)
references
References 35 publications
1
51
0
Order By: Relevance
“…MRI observation of sorafenib–pH-DENs deposition within the liver was later confirmed with histological staining of the tissue for iron with Prussian blue. 9,10 As shown in Figure 5b, strong blue signal was observed not only at the peripheral rim of the tumor (upper image) but also at the intratumor vessel (bottom image). These results indicate that sorafenib–pH-DENs were effectively localized to the targeted tumor regions, including the rim and inner tumor, via transcatheter IA liver-directed infusion.…”
Section: Resultsmentioning
confidence: 89%
“…MRI observation of sorafenib–pH-DENs deposition within the liver was later confirmed with histological staining of the tissue for iron with Prussian blue. 9,10 As shown in Figure 5b, strong blue signal was observed not only at the peripheral rim of the tumor (upper image) but also at the intratumor vessel (bottom image). These results indicate that sorafenib–pH-DENs were effectively localized to the targeted tumor regions, including the rim and inner tumor, via transcatheter IA liver-directed infusion.…”
Section: Resultsmentioning
confidence: 89%
“…Although clinical response was not significant, the microspheres accomplished the goal of in vivo tracking. The small size of the MSs may have been a contributing factor, carrying less drug than would a 300–500 μm MS. Another set of MRI visible drug eluting MSs using alginate, an anionic polysaccharide has been developed[121]. Alginate is composed of two uronic acid monomers: (1–4)-linked β-L-guluronic and α-D-mannuronic acids, and the monomers are linked via glycosidic bonds.…”
Section: Research and Development Of Advanced Materialsmentioning
confidence: 99%
“…[14] No systemic chemotherapy has proven to be effective in HCC patients, except for the oral multi-kinase inhibitor Sorafenib in advanced stage patients with good liver function. [5, 6] Transcatheter arterial chemoembolization (TACE) under image-guidance using X-ray angiography has been performed as the primary option for unresectable HCC with an advanced stage. TACE utilizes the preferential blood supply of HCC derived from the hepatic artery (~95%), thereby allowing local chemotherapy and embolization with minimal damage to the surrounding healthy parenchyma (primarily supplied via portal vein).…”
Section: Introductionmentioning
confidence: 99%
“…TACE utilizes the preferential blood supply of HCC derived from the hepatic artery (~95%), thereby allowing local chemotherapy and embolization with minimal damage to the surrounding healthy parenchyma (primarily supplied via portal vein). [6] Conventional TACE is performed with intra-arterial infusion of iodized oil mixed with chemotherapeutic agents such as Doxorubicin (Dox) or drug combinations such as Dox, cisplatin and mitomycin. [7] Lipiodol (Andre Guerbet, Aulnay-sous-Bois, France) is the iodized oil which has been most commonly used in TACE.…”
Section: Introductionmentioning
confidence: 99%